The Turkish Journal of Pediatrics 2007 , Vol 49 , Num 4
Burkitt’s lymphoma following a pediatric liver transplantation: predictive negative value of serologic response to Epstein-Barr virus
1Departments of Pediatric Gastroenterology, Akdeniz University Faculty of Medicine, Antalya, Turkey
2Departments of Pediatric Oncology, Akdeniz University Faculty of Medicine, Antalya, Turkey
3Departments of Pathology, Akdeniz University Faculty of Medicine, Antalya, Turkey
4Departments of Radiology, Akdeniz University Faculty of Medicine, Antalya, Turkey
Yılmaz A, Hazar V, Akçam M, İnanç-Gürer E, Çeken K, Artan R. Burkitt’s lymphoma following a pediatric liver transplantation: predictive negative value of serologic response to Epstein-Barr virus. Turk J Pediatr 2007; 49: 434-436.

Post-transplant lymphoproliferative disorder (PTLD) represents a spectrum of Epstein–Barr virus (EBV)-related clinical diseases, from a benign mononucleosislike illness to a fulminant non-Hodgkin’s lymphoma. Because a large proportion of children are seronegative at the time of transplantation, recipients are at high risk of contracting primary EBV infection and subsequently developing PTLD. Surveillance techniques with antibody titers and/or polymerase chain reaction (PCR) may have a role in some high-risk settings. A 12-year-old boy whose serologic response to EBV was negative during follow-up after liver transplantation (LTx) developed Burkitt’s lymphoma, a rare and the most severe variant of EBV-related PTLD, 32 months after LTx. He expired possibly due to side effects of treatment. We recommend that viral monitoring must be done using PCR during follow-up of pediatric LTx to prevent dramatic outcomes. Keywords : Liver transplantation, post-transplant lymphoproliferative disorder, Burkitt’s lymphoma, children, serologic response, polymerase chain reaction, Epstein- Barr virus

Copyright © 2016 turkishjournalpediatrics.org